• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Nutrien Reports Second Quarter 2025 Results

    8/6/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email
    • First half results supported by strong operational performance and favorable fertilizer market fundamentals.
    • Increasing 2025 full-year Potash sales volume guidance range, maintaining capital allocation priorities and continuing to show progress on 2026 performance targets.

    All amounts are in US dollars, except as otherwise noted

    Nutrien Ltd. (TSX and NYSE:NTR) announced today its second quarter 2025 results, with net earnings of $1.2 billion ($2.50 diluted net earnings per share). Second quarter 2025 adjusted EBITDA1 was $2.5 billion and adjusted net earnings per share1 was $2.65.

    "Nutrien delivered growth in earnings and cash flow in the first half of 2025, demonstrating strong operational performance and execution on our strategic priorities. We sold record Potash sales volumes, increased Nitrogen operating rates and lowered expenses, while further optimizing capital expenditures and consistently returning cash to shareholders," commented Ken Seitz, Nutrien's President and CEO.

    "Fertilizer market fundamentals are supported by strong global demand, persistent supply disruptions and project delays. We have seen healthy fertilizer customer engagement and field activity in North America to start the third quarter as farmers focus on maximizing crop yield potential," added Mr. Seitz.

    Highlights2:

    • Generated net earnings of $1.2 billion and adjusted EBITDA of $3.3 billion in the first half of 2025. Adjusted EBITDA increased from the same period in 2024 due to higher fertilizer sales volumes and net selling prices.
    • Retail adjusted EBITDA was $1.2 billion in the first half of 2025. Dry weather in Australia and wet conditions in the southern US impacted crop input sales and margins, offsetting the favorable impact of lower expenses and higher crop nutrient volumes in North America.
    • Potash adjusted EBITDA increased to $1.1 billion in the first half of 2025 due to higher net selling prices and record sales volumes, supported by strong demand in North America and key offshore markets.
    • Nitrogen adjusted EBITDA increased to $1.1 billion in the first half of 2025 due to higher net selling prices and sales volumes. Our operations delivered a record ammonia operating rate3 of 98 percent in the first half of 2025, achieved through improved reliability at our sites.
    • Returned $0.8 billion to shareholders in the first half of 2025 through dividends and share repurchases. We repurchased 5.7 million shares in 2025 for a total of $316 million, as of August 5, 2025.
    • Raising 2025 full-year Potash sales volume guidance to 13.9 to 14.5 million tonnes. All other full-year operational guidance ranges remain unchanged.
     

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    2 Our discussion of highlights set out on this page is a comparison of the results for the six months ended June 30, 2025 to the results for the six months ended June 30, 2024, unless otherwise noted.

    3 Excludes Trinidad and Joffre.

     

    Management's Discussion and Analysis

    The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of August 6, 2025. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 20, 2025 ("2024 Annual Report"), which includes our annual audited consolidated financial statements ("annual financial statements") and MD&A, and our annual information form dated February 20, 2025, each for the year ended December 31, 2024, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2024 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

    This MD&A is based on, and should be read in conjunction with, the Company's unaudited interim condensed consolidated financial statements as at and for the three and six months ended June 30, 2025 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the "Non-GAAP Financial Measures" and the "Forward-Looking Statements" sections, respectively.





    Market Outlook and Guidance

    Agriculture and Retail Markets

    • Favorable crop production prospects in the US and Brazil have pressured crop prices and prospective grower margins. Despite lower crop prices, demand for crop inputs in North America has been strong to start the third quarter of 2025 as farmers aim to maintain optimal plant health and yield potential.
    • Brazilian soybean acreage is expected to increase by one to three percent in 2025, supported by strong international soybean demand. Farmers in Brazil have been more active purchasing crop inputs in advance of the upcoming spring planting season compared to the prior two years.
    • In Australia, timely rains improved winter crop planting prospects and are expected to support crop input demand in the second half of 2025.

    Crop Nutrient Markets

    • Global potash demand in the first half of 2025 was supported by strong potash affordability and low channel inventories. The settlement of contracts with India and China in June and favorable economics for key crops grown in Southeast Asia is expected to support demand in standard grade markets in the second half of 2025. Solid uptake on our potash summer fill program in North America and stable demand in Brazil are expected to support third quarter shipments. As a result, we have raised our 2025 full-year global potash shipment forecast to 73 to 75 million tonnes.
    • Global urea supply and demand has remained tight, driven by strong seasonal demand from markets including India, combined with unplanned outages in key producing regions. US urea and UAN prices have been supported by low domestic inventories and trade flow shifts which we anticipate continuing in the second half of 2025.
    • Global ammonia prices have strengthened in the third quarter of 2025 due to plant outages, project delays and improved demand from phosphate producers.
    • Phosphate markets continue to be tight due to limited supply, including from Chinese export restrictions. We anticipate that global shipments in 2025 will be constrained by supply availability and weaker grower affordability for phosphate fertilizer could impact demand.

    Financial and Operational Guidance

    • Retail adjusted EBITDA guidance of $1.65 to $1.85 billion assumes higher North American crop nutrient and crop protection sales in the second half of 2025 compared to 2024, improved moisture conditions in Australia and continued recovery in Brazil.
    • Potash sales volume guidance was increased to 13.9 to 14.5 million tonnes due to expectations for higher global demand in 2025. The range is consistent with our historical share of global shipments.
    • Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes lower ammonia operating rates in the second half of 2025 compared to the record achieved in the first half of 2025 due to planned turnaround activity at our North American plants.
    • Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes improved operating rates and sales volumes in the second half of 2025 compared to the prior year with the completion of planned turnarounds in the first half of 2025.
    • Total capital expenditures of $2.0 to $2.1 billion are expected to be below the prior year. This total includes approximately $400 to $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions in Nitrogen and mine automation projects in Potash.
    • Effective tax rate on adjusted net earnings guidance was increased to 24.0% to 26.0% due to a change to our expected geographic mix of earnings.

    All guidance numbers, including those noted above, are outlined in the table below. Refer to page 58 of our 2024 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

     

    2025 Guidance Ranges 1 as of

     

    August 6, 2025

     

    May 7, 2025

    ($ billions, except as otherwise noted)

    Low

     

    High

     

    Low

     

    High

    Retail adjusted EBITDA

    1.65

     

    1.85

     

    1.65

     

    1.85

    Potash sales volumes (million tonnes) 2

    13.9

     

    14.5

     

    13.6

     

    14.4

    Nitrogen sales volumes (million tonnes) 2

    10.7

     

    11.2

     

    10.7

     

    11.2

    Phosphate sales volumes (million tonnes) 2

    2.35

     

    2.55

     

    2.35

     

    2.55

    Depreciation and amortization

    2.35

     

    2.45

     

    2.35

     

    2.45

    Finance costs

    0.65

     

    0.75

     

    0.65

     

    0.75

    Effective tax rate on adjusted net earnings (%) 3

    24.0

     

    26.0

     

    22.0

     

    25.0

    Capital expenditures 4

    2.0

     

    2.1

     

    2.0

     

    2.1

    1 See the "Forward-Looking Statements" section.

    2 Manufactured product only.

    3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

     

    Consolidated Results

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Sales

    10,438

     

    10,156

     

    3

     

    15,538

     

    15,545

     

    ‐

    Gross margin

    3,175

     

    2,912

     

    9

     

    4,495

     

    4,449

     

    1

    Expenses

    1,393

     

    2,068

     

    (33)

     

    2,487

     

    3,186

     

    (22)

    Net earnings

    1,229

     

    392

     

    214

     

    1,248

     

    557

     

    124

    Adjusted EBITDA 1

    2,486

     

    2,235

     

    11

     

    3,338

     

    3,290

     

    1

    Diluted net earnings per share (dollars) 2

    2.50

     

    0.78

     

    221

     

    2.52

     

    1.10

     

    129

    Adjusted net earnings per share (dollars) 1, 2

    2.65

     

    2.34

     

    13

     

    2.75

     

    2.81

     

    (2)

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    Net earnings and adjusted EBITDA increased in the second quarter and first half of 2025 compared to the same periods in 2024, primarily due to higher fertilizer sales volumes and net selling prices. Net earnings in the second quarter of 2024 were impacted by non-cash impairments of assets and a loss on foreign currency derivatives in Brazil.





    Segment Results

    Our discussion of segment results set out on the following pages is a comparison of the results for the three and six months ended June 30, 2025 to the results for the three and six months ended June 30, 2024, unless otherwise noted.

    Nutrien Ag Solutions ("Retail")

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Sales

    7,959

     

    8,074

     

    (1)

     

    11,049

     

    11,382

     

    (3)

    Cost of goods sold

    5,941

     

    6,045

     

    (2)

     

    8,345

     

    8,606

     

    (3)

    Gross margin

    2,018

     

    2,029

     

    (1)

     

    2,704

     

    2,776

     

    (3)

    Adjusted EBITDA 1

    1,149

     

    1,128

     

    2

     

    1,195

     

    1,205

     

    (1)

    1 See Note 2 to the interim financial statements.

    • Retail adjusted EBITDA increased in the second quarter of 2025 due to higher gross margin for crop nutrients and lower expenses, partially offset by lower seed margins. Dry weather in Australia and wet conditions in the southern US impacted crop input sales and margins in the first half of 2025, offsetting a six percent reduction in selling and general and administrative expenses and higher crop nutrient volumes in North America.

     

    Three Months Ended June 30

     

    Six Months Ended June 30

     

    Sales

     

    Gross Margin

     

    Sales

     

    Gross Margin

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Crop nutrients

    3,391

     

    3,281

     

    697

     

    686

     

    4,585

     

    4,590

     

    916

     

    940

    Crop protection products

    2,666

     

    2,733

     

    676

     

    677

     

    3,638

     

    3,847

     

    867

     

    911

    Seed

    1,278

     

    1,434

     

    266

     

    296

     

    1,810

     

    1,919

     

    336

     

    355

    Services and other

    286

     

    292

     

    235

     

    239

     

    432

     

    448

     

    353

     

    364

    Merchandise

    238

     

    245

     

    44

     

    42

     

    427

     

    445

     

    75

     

    73

    Nutrien Financial

    135

     

    133

     

    135

     

    133

     

    205

     

    199

     

    205

     

    199

    Nutrien Financial elimination 1

    (35)

     

    (44)

     

    (35)

     

    (44)

     

    (48)

     

    (66)

     

    (48)

     

    (66)

    Total

    7,959

     

    8,074

     

    2,018

     

    2,029

     

    11,049

     

    11,382

     

    2,704

     

    2,776

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    • Crop nutrients sales and gross margin increased in the second quarter of 2025 due to higher sales volumes and selling prices in North America, partially offset by lower sales volumes in Australia due to hot and dry conditions. First half of 2025 sales and gross margin were impacted by lower sales volumes due to strategic actions related to our margin improvement plan in Brazil.
    • Crop protection products sales and gross margin were lower in the second quarter and first half of 2025 due to hot and dry conditions in Australia and product mix shifts in North America.
    • Seed sales and gross margin decreased in the second quarter and first half of 2025 due to weather related impacts in the southern US leading to fewer planted acres which impacted proprietary products gross margin.

    Supplemental Data

    Three Months Ended June 30

     

    Six Months Ended June 30

     

    Gross Margin

     

    % of Product Line 1

     

    Gross Margin

     

    % of Product Line 1

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Proprietary products

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Crop nutrients

    228

     

    220

     

    33

     

    32

     

    297

     

    290

     

    32

     

    31

    Crop protection products

    246

     

    227

     

    37

     

    34

     

    299

     

    310

     

    34

     

    34

    Seed

    87

     

    127

     

    37

     

    44

     

    115

     

    144

     

    34

     

    41

    Merchandise

    3

     

    4

     

    6

     

    9

     

    6

     

    7

     

    7

     

    9

    Total

    564

     

    578

     

    29

     

    29

     

    717

     

    751

     

    27

     

    27

    1 Represents percentage of proprietary product margins over total product line gross margin.

     

     

    Three Months Ended June 30

     

    Six Months Ended June 30

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Crop nutrients

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America

    4,419

     

    4,298

     

    146

     

    146

     

    5,883

     

    5,762

     

    142

     

    144

    International

    1,072

     

    1,125

     

    48

     

    53

     

    1,898

     

    2,043

     

    42

     

    54

    Total

    5,491

     

    5,423

     

    127

     

    127

     

    7,781

     

    7,805

     

    118

     

    120

     

    (percentages)

    June 30, 2025

     

    December 31, 2024

    Financial performance measures 1, 2

     

     

     

    Cash operating coverage ratio

    63

     

    63

    Adjusted average working capital to sales

    21

     

    20

    Adjusted average working capital to sales excluding Nutrien Financial

    1

     

    -

    Nutrien Financial adjusted net interest margin

    5.3

     

    5.3

    1 Rolling four quarters.

    2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

    Potash

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    991

     

    756

     

    31

     

    1,735

     

    1,569

     

    11

    Cost of goods sold

    440

     

    359

     

    23

     

    820

     

    717

     

    14

    Gross margin

    551

     

    397

     

    39

     

    915

     

    852

     

    7

    Adjusted EBITDA 1

    630

     

    472

     

    33

     

    1,076

     

    1,002

     

    7

    1 See Note 2 to the interim financial statements.

    • Potash adjusted EBITDA increased in the second quarter and first half of 2025 due to higher net selling prices and record sales volumes, partially offset by higher provincial mining taxes.

    Manufactured Product

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    North America

    1,038

     

    914

     

    2,350

     

    2,221

    Offshore

    2,951

     

    2,649

     

    5,041

     

    4,755

    Total sales volumes

    3,989

     

    3,563

     

    7,391

     

    6,976

    Net selling price

     

     

     

     

     

     

     

    North America

    279

     

    301

     

    259

     

    306

    Offshore

    237

     

    182

     

    224

     

    187

    Average net selling price

    248

     

    212

     

    235

     

    225

    Cost of goods sold

    110

     

    101

     

    112

     

    103

    Gross margin

    138

     

    111

     

    123

     

    122

    Depreciation and amortization

    47

     

    42

     

    47

     

    43

    Gross margin excluding depreciation and amortization 1

    185

     

    153

     

    170

     

    165

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes in the second quarter and first half of 2025 were the highest on record, supported by healthy potash affordability and strong underlying consumption in North America and key offshore markets.
    • Net selling price per tonne increased in the second quarter and first half of 2025 driven by higher benchmark prices in Brazil and Southeast Asia, partially offset by lower benchmark prices in North America compared to the same periods last year.
    • Cost of goods sold per tonne increased in the second quarter and first half of 2025 primarily due to higher depreciation. Controllable cash cost of product manufactured per tonne increased in the first half of 2025 driven by lower planned potash production and higher turnaround costs.

    Supplemental Data

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (tonnes – thousands)

    3,531

     

    3,575

     

    6,820

     

    7,140

    Potash controllable cash cost of product manufactured per tonne 1

    55

     

    50

     

    57

     

    53

    Canpotex sales by market (percentage of sales volumes) 2

     

     

     

     

     

     

     

    Latin America

    42

     

    44

     

    37

     

    38

    Other Asian markets 3

    34

     

    27

     

    33

     

    30

    China

    8

     

    7

     

    12

     

    13

    India

    ‐

     

    8

     

    2

     

    6

    Other markets

    16

     

    14

     

    16

     

    13

    Total

    100

     

    100

     

    100

     

    100

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 See Note 8 to the interim financial statements.

    3 All Asian markets except China and India.

    Nitrogen

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    1,260

     

    1,028

     

    23

     

    2,214

     

    1,939

     

    14

    Cost of goods sold

    744

     

    650

     

    14

     

    1,407

     

    1,254

     

    12

    Gross margin

    516

     

    378

     

    37

     

    807

     

    685

     

    18

    Adjusted EBITDA 1

    667

     

    594

     

    12

     

    1,075

     

    1,058

     

    2

    1 See Note 2 to the interim financial statements.

    • Nitrogen adjusted EBITDA increased in the second quarter and first half of 2025 due to higher net selling prices and higher sales volumes, which more than offset higher natural gas costs and lower equity earnings from Profertil S.A. Second quarter of 2024 adjusted EBITDA benefited from insurance recoveries included in other income. Our operations delivered a record ammonia operating rate of 98 percent in the first half of 2025, achieved through improved reliability at our sites.

    Manufactured Product

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Ammonia

    734

     

    698

     

    1,230

     

    1,215

    Urea and ESN®

    961

     

    864

     

    1,756

     

    1,639

    Solutions, nitrates and sulfates

    1,322

     

    1,256

     

    2,500

     

    2,471

    Total sales volumes

    3,017

     

    2,818

     

    5,486

     

    5,325

    Net selling price

     

     

     

     

     

     

     

    Ammonia

    408

     

    405

     

    412

     

    404

    Urea and ESN®

    509

     

    445

     

    477

     

    438

    Solutions, nitrates and sulfates

    287

     

    238

     

    263

     

    232

    Average net selling price

    387

     

    343

     

    365

     

    335

    Cost of goods sold

    219

     

    211

     

    222

     

    209

    Gross margin

    168

     

    132

     

    143

     

    126

    Depreciation and amortization

    55

     

    54

     

    56

     

    54

    Gross margin excluding depreciation and amortization 1

    223

     

    186

     

    199

     

    180

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes increased in the second quarter and first half of 2025 due to strong demand and increased production of ammonia and upgraded nitrogen products.
    • Net selling price per tonne was higher in the second quarter and first half of 2025 for all major upgraded nitrogen products due to stronger benchmark prices. Ammonia net selling price per tonne was higher in the second quarter of 2025 despite lower global benchmark prices, reflecting the favorable mix of fertilizer sales in the quarter.
    • Cost of goods sold per tonne increased in the second quarter and first half of 2025 due to higher natural gas costs.

    Supplemental Data

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

     

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Fertilizer

    1,845

     

    1,716

     

    3,234

     

    3,139

    Industrial and feed

    1,172

     

    1,102

     

    2,252

     

    2,186

    Production volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Ammonia production – total 1

    1,535

     

    1,383

     

    3,078

     

    2,835

    Ammonia production – adjusted 1, 2

    1,088

     

    999

     

    2,164

     

    2,017

    Ammonia operating rate (%) 2

    98

     

    89

     

    98

     

    91

    Natural gas costs (dollars per MMBtu)

     

     

     

     

     

     

     

    Overall natural gas cost excluding realized derivative impact

    3.31

     

    2.65

     

    3.61

     

    2.91

    Realized derivative impact 3

    ‐

     

    0.10

     

    ‐

     

    0.07

    Overall natural gas cost

    3.31

     

    2.75

     

    3.61

     

    2.98

    1 All figures are provided on a gross production basis in thousands of product tonnes.

    2 Excludes Trinidad and Joffre.

    3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 3 to the interim financial statements.

    Phosphate

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    396

     

    394

     

    1

     

    756

     

    831

     

    (9)

    Cost of goods sold

    363

     

    361

     

    1

     

    724

     

    733

     

    (1)

    Gross margin

    33

     

    33

     

    ‐

     

    32

     

    98

     

    (67)

    Adjusted EBITDA 1

    92

     

    88

     

    5

     

    153

     

    209

     

    (27)

    1 See Note 2 to the interim financial statements.

    • Phosphate adjusted EBITDA was higher in the second quarter due to higher net selling prices, partially offset by lower sales volumes and higher sulfur input costs. Adjusted EBITDA for the first half of 2025 decreased due to the impact of lower production volumes and higher sulfur input costs, which more than offset higher net selling prices.

    Manufactured Product

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Fertilizer

    374

     

    415

     

    706

     

    862

    Industrial and feed

    169

     

    169

     

    337

     

    342

    Total sales volumes

    543

     

    584

     

    1,043

     

    1,204

    Net selling price

     

     

     

     

     

     

     

    Fertilizer

    666

     

    601

     

    661

     

    614

    Industrial and feed

    821

     

    830

     

    819

     

    839

    Average net selling price

    714

     

    667

     

    712

     

    678

    Cost of goods sold

    646

     

    602

     

    672

     

    590

    Gross margin

    68

     

    65

     

    40

     

    88

    Depreciation and amortization

    125

     

    116

     

    134

     

    115

    Gross margin excluding depreciation and amortization 1

    193

     

    181

     

    174

     

    203

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes were lower in the second quarter and first half of 2025 due to the impact of lower production volumes in the first quarter.
    • Net selling price per tonne increased in the second quarter and first half of 2025 due to strong phosphate fertilizer fundamentals and optimization of product mix, partially offset by lower industrial net selling prices which reflect the typical lag in price realizations relative to benchmark prices.
    • Cost of goods sold per tonne increased in the second quarter and first half of 2025 due to increased sulfur input costs, higher depreciation and the impact of lower production volumes in the first quarter.

    Supplemental Data

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (P2O5 tonnes – thousands)

    333

     

    326

     

    615

     

    678

    P2O5 operating rate (%)

    79

     

    77

     

    73

     

    80

     

    Corporate and Others and Eliminations

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Corporate and Others

     

     

     

     

     

     

     

     

     

     

     

    Gross margin 1

    1

     

    ‐

     

    n/m

     

    11

     

    ‐

     

    n/m

    Selling expenses

    (2)

     

    (3)

     

    (33)

     

    (5)

     

    (5)

     

    ‐

    General and administrative expenses

    95

     

    98

     

    (3)

     

    193

     

    187

     

    3

    Share-based compensation expense

    49

     

    10

     

    390

     

    91

     

    16

     

    469

    Foreign exchange loss, net of related derivatives

    22

     

    285

     

    (92)

     

    29

     

    328

     

    (91)

    Other expenses

    46

     

    26

     

    77

     

    64

     

    80

     

    (20)

    Adjusted EBITDA 1

    (104)

     

    (121)

     

    (14)

     

    (185)

     

    (222)

     

    (17)

    Eliminations

     

     

     

     

     

     

     

     

     

     

     

    Gross margin

    56

     

    75

     

    (25)

     

    26

     

    38

     

    (32)

    Adjusted EBITDA 1

    52

     

    74

     

    (30)

     

    24

     

    38

     

    (37)

    1 See Note 2 to the interim financial statements.

    • Share-based compensation expense was higher in the second quarter and first half of 2025 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors such as our share price movement, our performance relative to our peer group and our return on invested capital.
    • Foreign exchange loss, net of related derivatives was lower in the second quarter and first half of 2025 due to a lower loss on foreign currency derivatives in Brazil.

       

       

    Finance Costs, Income Taxes and Other Comprehensive Income (Loss)

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Finance costs

    155

     

    162

     

    (4)

     

    334

     

    341

     

    (2)

    Income taxes

     

     

     

     

     

     

     

     

     

     

     

    Income tax expense

    398

     

    290

     

    37

     

    426

     

    365

     

    17

    Actual effective tax rate including discrete items (%)

    24

     

    43

     

    (44)

     

    25

     

    40

     

    (38)

    Other comprehensive income (loss)

    184

     

    44

     

    318

     

    209

     

    (58)

     

    n/m

    • Income tax expense was higher in the second quarter and first half of 2025 mainly due to higher earnings. The decrease in the effective tax rate on ordinary earnings in the second quarter and first half of 2025 was mainly due to lower losses in South America.
    • Other comprehensive income (loss) is primarily driven by changes in the currency translation of our foreign operations. In the second quarter and first half of 2025, the gain was higher mainly due to the appreciation of the Brazilian, Australian and Canadian currencies, relative to the US dollar, compared to a depreciation of Brazilian and Canadian currencies relative to the US dollar for the same periods in 2024.





    Liquidity and Capital Resources

    Sources and uses of liquidity

    We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

    Sources and uses of cash

     

    Three Months Ended June 30

     

    Six Months Ended June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Cash provided by operating activities

    2,538

     

    1,807

     

    40

     

    1,456

     

    1,320

     

    10

    Cash used in investing activities

    (495)

     

    (614)

     

    (19)

     

    (738)

     

    (1,108)

     

    (33)

    Cash used in financing activities

    (1,572)

     

    (684)

     

    130

     

    (207)

     

    (136)

     

    52

    Cash used for dividends and share repurchases 1

    (373)

     

    (266)

     

    40

     

    (786)

     

    (527)

     

    49

    1 This is a supplementary financial measure. See the "Other Financial Measures" section.

     

    Cash provided by operating activities

    • Cash provided by operating activities in the second quarter was higher compared to the same period in 2024 due to higher fertilizer sales volumes and net selling prices. Cash provided by operating activities in the first half of 2025 was higher due to lower cash income taxes paid.

    Cash used in investing activities

    • Cash used in investing activities was lower in the second quarter and first half of 2025 due to lower capital expenditures. The first half of 2025 also included proceeds from the sale of our investment in Sinofert Holdings Limited ("Sinofert").

    Cash used in financing activities

    • Cash used in financing activities was higher in the second quarter of 2025 as $1.0 billion in senior notes were issued in the second quarter of 2024 with no comparable issuance in the second quarter of 2025. There was also a higher repayment of senior notes maturing in the second quarter of 2025 partially offset by increased commercial paper issuances. The first half of 2025 was higher compared to 2024, primarily from higher share repurchases.

    Cash used for dividends and share repurchases

    • Cash used for dividends and share repurchases was higher in the second quarter and first half of 2025 as a result of share repurchases in 2025 that did not occur in the same periods in 2024.

       

     
     

    Financial Condition Review

    The following is a comparison of balance sheet categories that are considered material:

     

    As at

     

     

     

     

    ($ millions, except as otherwise noted)

    June 30, 2025

     

    December 31, 2024

     

    $ Change

     

    % Change

    Assets

     

     

     

     

     

     

     

    Cash and cash equivalents

    1,387

     

    853

     

    534

     

    63

    Receivables

    8,086

     

    5,390

     

    2,696

     

    50

    Inventories

    5,576

     

    6,148

     

    (572)

     

    (9)

    Prepaid expenses and other current assets

    566

     

    1,401

     

    (835)

     

    (60)

    Property, plant and equipment

    22,496

     

    22,604

     

    (108)

     

    ‐

    Investments

    407

     

    698

     

    (291)

     

    (42)

    Liabilities and Shareholders' Equity

     

     

     

     

     

     

     

    Short-term debt

    1,882

     

    1,534

     

    348

     

    23

    Payables and accrued charges

    8,991

     

    9,118

     

    (127)

     

    (1)

    Long-term debt, including current portion

    10,405

     

    9,918

     

    487

     

    5

    Retained earnings

    11,719

     

    11,106

     

    613

     

    6

    • Explanations for changes in Cash and cash equivalents are in the "Liquidity and Capital Resources - Sources and uses of cash" section.
    • Receivables increased primarily due to the seasonality of Retail sales and higher Potash sales volumes.
    • Inventories decreased due to the seasonality of our Retail segment. Our North American inventory levels typically build up at year end in preparation for the following year's planting and application season and are drawn on in the succeeding quarters.
    • Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories during the planting and application season in North America.
    • Property, plant and equipment decreased due to depreciation more than offsetting capital expenditures.
    • Investments decreased due to the disposal of our remaining investment in Sinofert in the first half of 2025 and dividends received from Profertil S.A.
    • Short-term debt increased due to higher draws on our credit facilities based on our working capital requirements driven by the seasonality of our business.
    • Payables and accrued charges decreased due to lower customer prepayments in North America as Retail customers took delivery of prepaid sales, partially offset by higher income tax payable from strong earnings in the second quarter of 2025.
    • Long-term debt, including current portion, increased due to the issuance of $1,000 million of senior notes in the first quarter of 2025, partially offset by the repayment of $500 million of senior notes in the second quarter of 2025.
    • Retained earnings increased as net earnings exceeded dividends declared and share repurchases in the first half of 2025. 





    Capital Structure and Management

    Principal debt instruments

    As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the six months ended June 30, 2025.

    Capital structure (debt and equity)

    ($ millions)

    June 30, 2025

     

    December 31, 2024

    Short-term debt

    1,882

     

    1,534

    Current portion of long-term debt

    538

     

    1,037

    Current portion of lease liabilities

    363

     

    356

    Long-term debt

    9,867

     

    8,881

    Lease liabilities

    988

     

    999

    Shareholders' equity

    25,120

     

    24,442

    Commercial paper, credit facilities and other debt

    We have a total facility limit of approximately $8,030 million comprised of several credit facilities available in the jurisdictions where we operate. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

    As at June 30, 2025, we utilized $1,934 million of our total facility limit, which includes $1,654 million of commercial paper outstanding.

    As at June 30, 2025, $214 million in letters of credit were outstanding and committed, with $452 million of remaining credit available under our letter of credit facilities.

    Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2024 Annual Report for information on balances, rates and maturities for our notes and debentures. During the first half of 2025, we issued $400 million of 4.500 percent senior notes due March 12, 2027 and $600 million of 5.250 percent senior notes due March 12, 2032, and repaid our $500 million 3.000 percent senior notes upon maturity on April 1, 2025. See note 6 to the interim financial statements.

    Outstanding share data

     

    As at August 5, 2025

    Common shares

     485,884,041

    Options to purchase common shares

     2,680,721

    For more information on our capital management, see Note 4 to the annual financial statements in our 2024 Annual Report.





    Quarterly Results

    ($ millions, except as otherwise noted)

    Q2 2025

    Q1 2025

    Q4 2024

    Q3 2024

    Q2 2024

    Q1 2024

    Q4 2023

    Q3 2023

    Sales

    10,438

     

    5,100

     

    5,079

     

    5,348

     

    10,156

     

    5,389

     

    5,664

     

    5,631

    Net earnings

    1,229

     

    19

     

    118

     

    25

     

    392

     

    165

     

    176

     

    82

    Net earnings attributable to equity holders

    of Nutrien

    1,221

     

    11

     

    113

     

    18

     

    385

     

    158

     

    172

     

    75

    Net earnings per share attributable to equity

    holders of Nutrien

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

    2.51

     

    0.02

     

    0.23

     

    0.04

     

    0.78

     

    0.32

     

    0.35

     

    0.15

    Diluted

    2.50

     

    0.02

     

    0.23

     

    0.04

     

    0.78

     

    0.32

     

    0.35

     

    0.15

     

    Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, which have been volatile over the last two years and are affected by demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.

    The following table describes certain items that impacted our quarterly earnings:

    Quarter

    Transaction or Event

    Q2 2024

    $530 million non-cash impairment of assets comprised of a $335 million non-cash impairment of our Retail – Brazil intangible assets and property plant and equipment due to the ongoing market instability and more moderate margin expectations, and a $195 million non-cash impairment of our Geismar Clean Ammonia project property, plant and equipment as we are no longer pursuing the project. Net earnings also included a foreign exchange loss of $220 million on foreign currency derivatives in Brazil.

     
     

    Critical Accounting Estimates

    Our significant accounting policies are disclosed in our 2024 Annual Report. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board. Our critical accounting estimates are discussed on pages 65 to 66 of our 2024 Annual Report. There were no material changes to our critical accounting estimates for the three or six months ended June 30, 2025.





    Controls and Procedures

    Management is responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR"), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

    There has been no change in our ICFR during the three months ended June 30, 2025, that has materially affected, or is reasonably likely to materially affect, our ICFR.





    Forward-Looking Statements

    Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to:

    Nutrien's business strategies, plans, prospects and opportunities; Nutrien's revised 2025 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding our capital allocation intentions and strategies; our ability to advance strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow; capital spending expectations for 2025 and beyond; expectations regarding performance of our operating segments in 2025 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, including the expected impact of supply availability on global shipments of phosphate fertilizer and the expected impact of affordability on demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; expectations regarding demand in standard grade markets for the second half of 2025; the expected impact of uptake on Nutrien's summer fill program on third quarter shipments; expectations regarding the demand for crop inputs in North America and Australia; the anticipated inventory levels and trade flow shifts in the second half of 2025 and into 2026 and the expected impact on US urea and UAN prices; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders.

    These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

    All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

    The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures; increased proprietary products gross margin; continued Retail recovery in Brazil; a return to historical average crop protection product margin percentages; continued reliability improvements; higher operating rates in Phosphate and Nitrogen; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets and normalization of Canpotex port operations; global economic conditions and the accuracy of our market outlook expectations for 2025 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

    Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets, such as our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

    The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

    The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.





    Terms and Definitions

    For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2024 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.





    About Nutrien

    Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

    More information about Nutrien can be found at www.nutrien.com.

    Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

    Such data is not incorporated by reference herein.

    Nutrien will host a Conference Call on Thursday, August 7, 2025 at 10:00 a.m. Eastern Time.

    Telephone conference dial-in numbers:

    • From Canada and the US: 1 (800) 206-4400
    • International: 1 (289) 514-5005
    • No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

    Live Audio Webcast: Visit https://www.nutrien.com/news/events/2025-q2-earnings-conference-call





    Non-GAAP Financial Measures

    We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

    These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

    The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

    Adjusted EBITDA (Consolidated)

    Most directly comparable IFRS financial measure: Net earnings (loss).

    Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

    Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

     

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Net earnings

    1,229

     

    392

     

    1,248

     

    557

    Finance costs

    155

     

    162

     

    334

     

    341

    Income tax expense

    398

     

    290

     

    426

     

    365

    Depreciation and amortization

    614

     

    586

     

    1,185

     

    1,151

    EBITDA 1

    2,396

     

    1,430

     

    3,193

     

    2,414

    Adjustments:

     

     

     

     

     

     

     

    Share-based compensation expense

    49

     

    10

     

    91

     

    16

    Foreign exchange loss, net of related derivatives

    22

     

    285

     

    29

     

    328

    ARO/ERL related (income) expenses for

    non-operating sites

    (2)

     

    (35)

     

    3

     

    (32)

    Loss related to financial instruments in Argentina

    ‐

     

    15

     

    ‐

     

    34

    Restructuring costs

    21

     

    ‐

     

    22

     

    ‐

    Impairment of assets

    ‐

     

    530

     

    ‐

     

    530

    Adjusted EBITDA

    2,486

     

    2,235

     

    3,338

     

    3,290

    1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

     

    Adjusted Net Earnings and Adjusted Net Earnings Per Share

    Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

    Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

     

    Three Months Ended

    June 30, 2025

     

    Six Months Ended

    June 30, 2025

    ($ millions, except as otherwise noted)

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

     

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    1,221

     

    2.50

     

     

     

    1,232

     

    2.52

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    49

     

    37

     

    0.08

     

    91

     

    68

     

    0.14

    Foreign exchange loss, net of related derivatives

    22

     

    17

     

    0.04

     

    29

     

    23

     

    0.05

    Restructuring costs

    21

     

    17

     

    0.03

     

    22

     

    18

     

    0.04

    ARO/ERL related (income) expenses for non-operating sites

    (2)

     

    (1)

     

    ‐

     

    3

     

    3

     

    ‐

    Sub-total adjustments

    90

     

    70

     

    0.15

     

    145

     

    112

     

    0.23

    Adjusted net earnings

     

     

    1,291

     

    2.65

     

     

     

    1,344

     

    2.75

     

     

    Three Months Ended

    June 30, 2024

     

    Six Months Ended

    June 30, 2024

    ($ millions, except as otherwise noted)

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

     

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    385

     

    0.78

     

     

     

    543

     

    1.10

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    10

     

    8

     

    0.02

     

    16

     

    12

     

    0.02

    Foreign exchange loss, net of related derivatives

    285

     

    283

     

    0.57

     

    328

     

    333

     

    0.67

    Impairment of assets

    530

     

    491

     

    1.00

     

    530

     

    491

     

    1.00

    ARO/ERL related (income) for non-operating sites

    (35)

     

    (25)

     

    (0.06)

     

    (32)

     

    (23)

     

    (0.05)

    Loss related to financial instruments in Argentina

    15

     

    15

     

    0.03

     

    34

     

    34

     

    0.07

    Sub-total adjustments

    805

     

    772

     

    1.56

     

    876

     

    847

     

    1.71

    Adjusted net earnings

     

     

    1,157

     

    2.34

     

     

     

    1,390

     

    2.81

     

    Effective Tax Rate on Adjusted Net Earnings Guidance

    Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

    Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

    Most directly comparable IFRS financial measure: Gross margin.

    Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

    Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

    Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

    Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

    Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

     

    Three Months Ended

    June 30

     

    Six Months Ended

    June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Total COGS – Potash

    440

     

    359

     

    820

     

    717

    Change in inventory

    (58)

     

    (7)

     

    (51)

     

    21

    Other adjustments 1

    (8)

     

    (6)

     

    (21)

     

    (9)

    COPM

    374

     

    346

     

    748

     

    729

    Depreciation and amortization in COPM

    (147)

     

    (141)

     

    (292)

     

    (294)

    Royalties in COPM

    (23)

     

    (20)

     

    (42)

     

    (39)

    Natural gas costs and carbon taxes in COPM

    (10)

     

    (8)

     

    (22)

     

    (20)

    Controllable cash COPM

    194

     

    177

     

    392

     

    376

    Production volumes (tonnes – thousands)

    3,531

     

    3,575

     

    6,820

     

    7,140

    Potash controllable cash COPM per tonne

    55

     

    50

     

    57

     

    53

    1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

    Nutrien Financial Adjusted Net Interest Margin

    Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

     

    Rolling Four Quarters Ended June 30, 2025

    ($ millions, except as otherwise noted)

    Q3 2024

     

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Total/Average

    Nutrien Financial revenue

    85

     

    77

     

    70

     

    135

     

     

    Deemed interest expense 1

    (52)

     

    (45)

     

    (29)

     

    (49)

     

     

    Net interest

    33

     

    32

     

    41

     

    86

     

    192

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    4,318

     

    2,877

     

    2,569

     

    4,645

     

    3,602

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.3

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total/Average

    Nutrien Financial revenue

    66

     

    133

     

    85

     

    77

     

     

    Deemed interest expense 1

    (27)

     

    (50)

     

    (52)

     

    (45)

     

     

    Net interest

    39

     

    83

     

    33

     

    32

     

    187

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,489

     

    4,560

     

    4,318

     

    2,877

     

    3,561

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.3

    1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

     

    Retail Cash Operating Coverage Ratio

    Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

     

    Rolling Four Quarters Ended June 30, 2025

    ($ millions, except as otherwise noted)

    Q3 2024

     

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Total

    Selling expenses

    815

     

    808

     

    755

     

    948

     

    3,326

    General and administrative expenses

    51

     

    37

     

    44

     

    44

     

    176

    Other expenses (income)

    32

     

    (8)

     

    25

     

    54

     

    103

    Operating expenses

    898

     

    837

     

    824

     

    1,046

     

    3,605

    Depreciation and amortization in operating expenses

    (182)

     

    (186)

     

    (179)

     

    (172)

     

    (719)

    Operating expenses excluding depreciation and amortization

    716

     

    651

     

    645

     

    874

     

    2,886

     

     

     

     

     

     

     

     

     

     

    Gross margin

    859

     

    986

     

    686

     

    2,018

     

    4,549

    Depreciation and amortization in cost of goods sold

    8

     

    5

     

    5

     

    5

     

    23

    Gross margin excluding depreciation and amortization

    867

     

    991

     

    691

     

    2,023

     

    4,572

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    63

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total

    Selling expenses

    790

     

    1,005

     

    815

     

    808

     

    3,418

    General and administrative expenses

    52

     

    51

     

    51

     

    37

     

    191

    Other expenses (income)

    22

     

    41

     

    32

     

    (8)

     

    87

    Operating expenses

    864

     

    1,097

     

    898

     

    837

     

    3,696

    Depreciation and amortization in operating expenses

    (190)

     

    (193)

     

    (182)

     

    (186)

     

    (751)

    Operating expenses excluding depreciation and amortization

    674

     

    904

     

    716

     

    651

     

    2,945

     

     

     

     

     

     

     

     

     

     

    Gross margin

    747

     

    2,029

     

    859

     

    986

     

    4,621

    Depreciation and amortization in cost of goods sold

    4

     

    3

     

    8

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    751

     

    2,032

     

    867

     

    991

     

    4,641

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    63

     

    Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

    Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

    Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

     

    Rolling Four Quarters Ended June 30, 2025

    ($ millions, except as otherwise noted)

    Q3 2024

     

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Average/Total

    Current assets

    10,559

     

    10,360

     

    11,510

     

    11,442

     

     

    Current liabilities

    (5,263)

     

    (8,028)

     

    (7,561)

     

    (8,051)

     

     

    Working capital

    5,296

     

    2,332

     

    3,949

     

    3,391

     

    3,742

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    5,296

     

    2,332

     

    3,949

     

    3,391

     

    3,742

    Nutrien Financial working capital

    (4,318)

     

    (2,877)

     

    (2,569)

     

    (4,645)

     

     

    Adjusted working capital excluding Nutrien Financial

    978

     

    (545)

     

    1,380

     

    (1,254)

     

    140

     

     

     

     

     

     

     

     

     

     

    Sales

    3,271

     

    3,179

     

    3,090

     

    7,959

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,271

     

    3,179

     

    3,090

     

    7,959

     

    17,499

    Nutrien Financial revenue

    (85)

     

    (77)

     

    (70)

     

    (135)

     

     

    Adjusted sales excluding Nutrien Financial

    3,186

     

    3,102

     

    3,020

     

    7,824

     

    17,132

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    21

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    1

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Average/Total

    Current assets

    11,821

     

    11,181

     

    10,559

     

    10,360

     

     

    Current liabilities

    (8,401)

     

    (8,002)

     

    (5,263)

     

    (8,028)

     

     

    Working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Nutrien Financial working capital

    (2,489)

     

    (4,560)

     

    (4,318)

     

    (2,877)

     

     

    Adjusted working capital excluding Nutrien Financial

    931

     

    (1,381)

     

    978

     

    (545)

     

    (4)

     

     

     

     

     

     

     

     

     

     

    Sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

    17,832

    Nutrien Financial revenue

    (66)

     

    (133)

     

    (85)

     

    (77)

     

     

    Adjusted sales excluding Nutrien Financial

    3,242

     

    7,941

     

    3,186

     

    3,102

     

    17,471

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    20

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    ‐

     
     

    Other Financial Measures

    Selected Additional Financial Data

    Nutrien Financial

    As at June 30, 2025

    As at

    December 31, 2024

    ($ millions)

    Current

    <31 Days

    Past Due

    31–90 Days

    Past Due

    >90 Days

    Past Due

    Gross Receivables

    Allowance 1

    Net

    Receivables 2

    Net

    Receivables

    North America

    3,384

    192

    62

    257

    3,895

    (76)

    3,819

    2,178

    International

    724

    55

    17

    43

    839

    (13)

    826

    699

    Nutrien Financial receivables

    4,108

    247

    79

    300

    4,734

    (89)

    4,645

    2,877

    1 Bad debt expense on the above receivables for the six months ended June 30, 2025 were $38 million, in the Retail segment.

    2 In 2025, we assume a debt-to-equity ratio of 9:1 (2024 – 7:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

    Supplementary Financial Measures

    Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

    The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

    Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

    Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

    Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

    Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.





    Condensed Consolidated Financial Statements





    Unaudited

    Condensed Consolidated Statements of Earnings

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30

     

    June 30

    ($ millions, except as otherwise noted)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Sales

    2, 8

    10,438

     

    10,156

     

    15,538

     

    15,545

    Freight, transportation and distribution

     

    240

     

    240

     

    466

     

    478

    Cost of goods sold

     

    7,023

     

    7,004

     

    10,577

     

    10,618

    Gross Margin

     

    3,175

     

    2,912

     

    4,495

     

    4,449

    Selling expenses

     

    951

     

    1,008

     

    1,708

     

    1,802

    General and administrative expenses

     

    148

     

    158

     

    300

     

    312

    Provincial mining taxes

     

    97

     

    68

     

    165

     

    136

    Share-based compensation expense

     

    49

     

    10

     

    91

     

    16

    Impairment of assets

     

    ‐

     

    530

     

    ‐

     

    530

    Foreign exchange loss, net of related derivatives

    5

    22

     

    285

     

    29

     

    328

    Other expenses

    3

    126

     

    9

     

    194

     

    62

    Earnings Before Finance Costs and Income Taxes

    1,782

     

    844

     

    2,008

     

    1,263

    Finance costs

     

    155

     

    162

     

    334

     

    341

    Earnings Before Income Taxes

     

    1,627

     

    682

     

    1,674

     

    922

    Income tax expense

    4

    398

     

    290

     

    426

     

    365

    Net Earnings

     

    1,229

     

    392

     

    1,248

     

    557

    Attributable to

     

     

     

     

     

     

     

     

    Equity holders of Nutrien

     

    1,221

     

    385

     

    1,232

     

    543

    Non-controlling interest

     

    8

     

    7

     

    16

     

    14

    Net Earnings

     

    1,229

     

    392

     

    1,248

     

    557

     

     

     

     

     

     

     

     

     

    Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

    Basic

     

    2.51

     

    0.78

     

    2.52

     

    1.10

    Diluted

     

    2.50

     

    0.78

     

    2.52

     

    1.10

    Weighted average shares outstanding for basic EPS

     

    487,396,000

     

    494,646,000

     

    488,391,000

     

    494,608,000

    Weighted average shares outstanding for diluted EPS

     

    487,598,000

     

    494,915,000

     

    488,563,000

     

    494,851,000

     

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Condensed Consolidated Statements of Comprehensive Income

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions, net of related income taxes)

    2025

     

    2024

     

    2025

     

    2024

    Net Earnings

    1,229

     

    392

     

    1,248

     

    557

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Item that will not be reclassified to net earnings:

     

     

     

     

     

     

     

    Net fair value gain (loss) on investments

    ‐

     

    36

     

    (18)

     

    18

    Items that have been or may be subsequently reclassified to net earnings:

     

     

     

     

     

     

     

    Gain (loss) on currency translation of foreign operations

    162

     

    9

     

    201

     

    (57)

    Other

    22

     

    (1)

     

    26

     

    (19)

    Other Comprehensive Income (Loss)

    184

     

    44

     

    209

     

    (58)

    Comprehensive Income

    1,413

     

    436

     

    1,457

     

    499

    Attributable to

     

     

     

     

     

     

     

    Equity holders of Nutrien

    1,404

     

    429

     

    1,440

     

    486

    Non-controlling interest

    9

     

    7

     

    17

     

    13

    Comprehensive Income

    1,413

     

    436

     

    1,457

     

    499

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Condensed Consolidated Statements of Cash Flows

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30

     

    June 30

    ($ millions)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Operating Activities

     

     

     

     

     

     

     

     

    Net earnings

     

    1,229

     

    392

     

    1,248

     

    557

    Adjustments for:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    614

     

    586

     

    1,185

     

    1,151

    Share-based compensation expense

     

    49

     

    10

     

    91

     

    16

    Impairment of assets

     

    ‐

     

    530

     

    ‐

     

    530

    (Recovery of) provision for deferred income tax

     

    (48)

     

    23

     

    32

     

    51

    Net distributed earnings of equity-accounted investees

     

    90

     

    88

     

    85

     

    38

    Fair value adjustment to derivatives

    5

    2

     

    187

     

    8

     

    186

    Loss related to financial instruments in Argentina

    3

    ‐

     

    15

     

    ‐

     

    34

    Long-term income tax receivables and payables

     

    54

     

    (35)

     

    16

     

    8

    Other long-term assets, liabilities and miscellaneous

     

    (39)

     

    5

     

    (40)

     

    70

    Cash from operations before working capital changes

     

    1,951

     

    1,801

     

    2,625

     

    2,641

    Changes in non-cash operating working capital:

     

     

     

     

     

     

     

     

    Receivables

     

    (2,462)

     

    (2,555)

     

    (2,605)

     

    (2,812)

    Inventories and prepaid expenses and other current assets

     

    2,894

     

    3,222

     

    1,620

     

    1,892

    Payables and accrued charges

     

    155

     

    (661)

     

    (184)

     

    (401)

    Cash Provided by Operating Activities

     

    2,538

     

    1,807

     

    1,456

     

    1,320

    Investing Activities

     

     

     

     

     

     

     

     

    Capital expenditures 1

     

    (424)

     

    (526)

     

    (724)

     

    (879)

    Business acquisitions, net of cash acquired

     

    ‐

     

    (4)

     

    (11)

     

    (4)

    (Purchase of) proceeds from investments, held within three months, net

     

    (53)

     

    3

     

    (69)

     

    (15)

    Purchase of investments

     

    (91)

     

    (107)

     

    (93)

     

    (111)

    Proceeds from sale of investments

    5

    93

     

    18

     

    276

     

    18

    Net changes in non-cash working capital

     

    10

     

    5

     

    (78)

     

    (85)

    Other

     

    (30)

     

    (3)

     

    (39)

     

    (32)

    Cash Used in Investing Activities

     

    (495)

     

    (614)

     

    (738)

     

    (1,108)

    Financing Activities

     

     

     

     

     

     

     

     

    (Repayment of) proceeds from debt, maturing within three months, net

     

    (578)

     

    (1,215)

     

    334

     

    (289)

    Proceeds from debt

    6

    ‐

     

    998

     

    998

     

    998

    Repayment of debt

    6

    (531)

     

    (75)

     

    (535)

     

    (89)

    Repayment of principal portion of lease liabilities

     

    (106)

     

    (106)

     

    (216)

     

    (202)

    Dividends paid to Nutrien's shareholders

    7

    (268)

     

    (266)

     

    (533)

     

    (527)

    Repurchase of common shares, inclusive of related tax

    7

    (105)

     

    ‐

     

    (253)

     

    ‐

    Issuance of common shares

     

    26

     

    8

     

    29

     

    9

    Other

     

    (10)

     

    (28)

     

    (31)

     

    (36)

    Cash Used in Financing Activities

     

    (1,572)

     

    (684)

     

    (207)

     

    (136)

    Effect of Exchange Rate Changes on Cash and Cash Equivalents

     

    21

     

    (1)

     

    23

     

    (13)

    Increase in Cash and Cash Equivalents

     

    492

     

    508

     

    534

     

    63

    Cash and Cash Equivalents – Beginning of Period

     

    895

     

    496

     

    853

     

    941

    Cash and Cash Equivalents – End of Period

     

    1,387

     

    1,004

     

    1,387

     

    1,004

    Cash and cash equivalents is composed of:

     

     

     

     

     

     

     

     

    Cash

     

    1,228

     

    953

     

    1,228

     

    953

    Short-term investments

     

    159

     

    51

     

    159

     

    51

     

     

    1,387

     

    1,004

     

    1,387

     

    1,004

    Supplemental Cash Flows Information

     

     

     

     

     

     

     

     

    Interest paid

     

    220

     

    216

     

    352

     

    348

    Income taxes (received) paid

     

    (19)

     

    83

     

    (12)

     

    133

    Total cash outflow for leases

     

    139

     

    153

     

    289

     

    284

    1 Includes additions to property, plant and equipment, and intangible assets for the three months ended June 30, 2025 of $398 million and $26 million (2024 – $491 million and $35 million), respectively, and for the six months ended June 30, 2025 of $677 million and $47 million (2024 – $815 million and $64 million), respectively.

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Changes in Shareholders' Equity

     

     

     

     

     

     

     

    Accumulated Other Comprehensive

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (Loss) Income ("AOCI")

     

     

     

     

     

     

     

    ($ millions, inclusive of related tax, except as otherwise noted)

    Number of

    Common

    Shares

     

    Share

    Capital

     

    Contributed

    Surplus

     

    (Loss) Gain

    on Currency

    Translation

    of Foreign

    Operations

     

    Other

     

    Total

    AOCI

     

    Retained

    Earnings

     

    Equity

    Holders

    of

    Nutrien

     

    Non-

    Controlling

    Interest

     

    Total

    Equity

    Balance – December 31, 2023

    494,551,730

     

    13,838

     

    83

     

    (286)

     

    (10)

     

    (296)

     

    11,531

     

    25,156

     

    45

     

    25,201

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    543

     

    543

     

    14

     

    557

    Other comprehensive loss

    ‐

     

    ‐

     

    ‐

     

    (56)

     

    (1)

     

    (57)

     

    ‐

     

    (57)

     

    (1)

     

    (58)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (532)

     

    (532)

     

    ‐

     

    (532)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (26)

     

    (26)

    Effect of share-based compensation including

    issuance of common shares

    153,808

     

    8

     

    3

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    11

     

    ‐

     

    11

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    8

     

    8

     

    ‐

     

    8

     

    ‐

     

    8

    Other

    ‐

     

    ‐

     

    ‐

     

    (2)

     

    ‐

     

    (2)

     

    ‐

     

    (2)

     

    ‐

     

    (2)

    Balance – June 30, 2024

    494,705,538

     

    13,846

     

    86

     

    (344)

     

    (3)

     

    (347)

     

    11,542

     

    25,127

     

    32

     

    25,159

    Balance – December 31, 2024

    491,025,446

     

    13,748

     

    68

     

    (537)

     

    22

     

    (515)

     

    11,106

     

    24,407

     

    35

     

    24,442

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1,232

     

    1,232

     

    16

     

    1,248

    Other comprehensive income

    ‐

     

    ‐

     

    ‐

     

    200

     

    8

     

    208

     

    ‐

     

    208

     

    1

     

    209

    Shares repurchased for cancellation (Note 7)

    (4,741,786)

     

    (133)

     

    (10)

     

    ‐

     

    ‐

     

    ‐

     

    (114)

     

    (257)

     

    ‐

     

    (257)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (533)

     

    (533)

     

    ‐

     

    (533)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (21)

     

    (21)

    Effect of share-based compensation including

    issuance of common shares

    581,799

     

    35

     

    (3)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    32

     

    ‐

     

    32

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (27)

     

    (27)

     

    27

     

    ‐

     

    ‐

     

    ‐

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    1

     

    ‐

     

    1

     

    ‐

     

    1

    Other

    ‐

     

    ‐

     

    ‐

     

    (2)

     

    ‐

     

    (2)

     

    1

     

    (1)

     

    ‐

     

    (1)

    Balance – June 30, 2025

    486,865,459

     

    13,650

     

    55

     

    (339)

     

    4

     

    (335)

     

    11,719

     

    25,089

     

    31

     

    25,120

    1 During the six months ended June 30, 2025, we declared dividends of $1.09 per share (2024 - $1.08 per share).

     

    (See Notes to the Condensed Consolidated Financial Statements)

     
     

    Condensed Consolidated Balance Sheets

     

     

     

     

     

     

    As at

     

     

    As at June 30

     

    December 31,

    ($ millions)

    Note

    2025

     

    2024

     

    2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    1,387

     

    1,004

     

    853

    Receivables

    8

    8,086

     

    8,123

     

    5,390

    Inventories

     

    5,576

     

    5,298

     

    6,148

    Prepaid expenses and other current assets

     

    566

     

    663

     

    1,401

     

     

    15,615

     

    15,088

     

    13,792

    Non-current assets

     

     

     

     

     

     

    Property, plant and equipment

     

    22,496

     

    22,198

     

    22,604

    Goodwill

     

    12,121

     

    12,094

     

    12,043

    Intangible assets

     

    1,745

     

    1,912

     

    1,819

    Investments

    5

    407

     

    703

     

    698

    Other assets

     

    871

     

    996

     

    884

    Total Assets

     

    53,255

     

    52,991

     

    51,840

    Liabilities

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Short-term debt

     

    1,882

     

    1,571

     

    1,534

    Current portion of long-term debt

    6

    538

     

    1,012

     

    1,037

    Current portion of lease liabilities

     

    363

     

    364

     

    356

    Payables and accrued charges

     

    8,991

     

    9,024

     

    9,118

     

     

    11,774

     

    11,971

     

    12,045

    Non-current liabilities

     

     

     

     

     

     

    Long-term debt

    6

    9,867

     

    9,399

     

    8,881

    Lease liabilities

     

    988

     

    1,024

     

    999

    Deferred income tax liabilities

     

    3,512

     

    3,615

     

    3,539

    Pension and other post-retirement benefit liabilities

     

    232

     

    245

     

    227

    Asset retirement obligations and accrued environmental costs

     

    1,536

     

    1,406

     

    1,543

    Other non-current liabilities

     

    226

     

    172

     

    164

    Total Liabilities

     

    28,135

     

    27,832

     

    27,398

    Shareholders' Equity

     

     

     

     

     

     

    Share capital

    7

    13,650

     

    13,846

     

    13,748

    Contributed surplus

     

    55

     

    86

     

    68

    Accumulated other comprehensive loss

     

    (335)

     

    (347)

     

    (515)

    Retained earnings

     

    11,719

     

    11,542

     

    11,106

    Equity holders of Nutrien

     

    25,089

     

    25,127

     

    24,407

    Non-controlling interest

     

    31

     

    32

     

    35

    Total Shareholders' Equity

     

    25,120

     

    25,159

     

    24,442

    Total Liabilities and Shareholders' Equity

     

    53,255

     

    52,991

     

    51,840

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Notes to the Condensed Consolidated Financial Statements

    As at and for the Three and Six Months Ended June 30, 2025

    Note 1 Basis of presentation

    Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

    These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2024 annual audited consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2024 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

    Certain immaterial 2024 figures have been reclassified in the condensed consolidated statements of cash flows.

    In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized for issue by the Audit Committee of the Board of Directors on August 6, 2025.

    Note 2 Segment information

    We have four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core business. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

    Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments received are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Assets – as at June 30, 2025

    23,241

     

    14,110

     

    11,651

     

    2,501

     

    2,683

     

    (931)

     

    53,255

    Assets – as at December 31, 2024

    22,149

     

    13,792

     

    11,603

     

    2,453

     

    2,571

     

    (728)

     

    51,840

     

     

     

    Three Months Ended June 30, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    7,959

     

    992

     

    1,104

     

    382

     

    1

     

    ‐

     

    10,438

     

    – intersegment

    ‐

     

    93

     

    309

     

    67

     

    ‐

     

    (469)

     

    ‐

    Sales

    – total

    7,959

     

    1,085

     

    1,413

     

    449

     

    1

     

    (469)

     

    10,438

    Freight, transportation and

    distribution

    ‐

     

    94

     

    153

     

    53

     

    ‐

     

    (60)

     

    240

    Net sales

    7,959

     

    991

     

    1,260

     

    396

     

    1

     

    (409)

     

    10,198

    Cost of goods sold

    5,941

     

    440

     

    744

     

    363

     

    ‐

     

    (465)

     

    7,023

    Gross margin

    2,018

     

    551

     

    516

     

    33

     

    1

     

    56

     

    3,175

    Selling expenses (recovery)

    948

     

    2

     

    8

     

    1

     

    (2)

     

    (6)

     

    951

    General and administrative

    expenses

    44

     

    2

     

    6

     

    1

     

    95

     

    ‐

     

    148

    Provincial mining taxes

    ‐

     

    97

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    97

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    49

     

    ‐

     

    49

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    22

     

    ‐

     

    22

    Other expenses

    54

     

    8

     

    1

     

    7

     

    46

     

    10

     

    126

    Earnings (loss) before finance costs

    and income taxes

    972

     

    442

     

    501

     

    24

     

    (209)

     

    52

     

    1,782

    Depreciation and amortization

    177

     

    188

     

    166

     

    68

     

    15

     

    ‐

     

    614

    EBITDA

    1,149

     

    630

     

    667

     

    92

     

    (194)

     

    52

     

    2,396

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    21

     

    ‐

     

    21

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    49

     

    ‐

     

    49

    ARO/ERL related expenses for

    non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (2)

     

    ‐

     

    (2)

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    22

     

    ‐

     

    22

    Adjusted EBITDA

    1,149

     

    630

     

    667

     

    92

     

    (104)

     

    52

     

    2,486

     

     

     

    Three Months Ended June 30, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    8,074

     

    750

     

    948

     

    384

     

    ‐

     

    ‐

     

    10,156

     

    – intersegment

    ‐

     

    86

     

    239

     

    67

     

    ‐

     

    (392)

     

    ‐

    Sales

    – total

    8,074

     

    836

     

    1,187

     

    451

     

    ‐

     

    (392)

     

    10,156

    Freight, transportation and

    distribution

    ‐

     

    80

     

    159

     

    57

     

    ‐

     

    (56)

     

    240

    Net sales

    8,074

     

    756

     

    1,028

     

    394

     

    ‐

     

    (336)

     

    9,916

    Cost of goods sold

    6,045

     

    359

     

    650

     

    361

     

    ‐

     

    (411)

     

    7,004

    Gross margin

    2,029

     

    397

     

    378

     

    33

     

    ‐

     

    75

     

    2,912

    Selling expenses (recovery)

    1,005

     

    3

     

    8

     

    2

     

    (3)

     

    (7)

     

    1,008

    General and administrative

    expenses

    51

     

    1

     

    5

     

    3

     

    98

     

    ‐

     

    158

    Provincial mining taxes

    ‐

     

    68

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    68

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    10

     

    ‐

     

    10

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    285

     

    ‐

     

    285

    Other expenses (income)

    41

     

    4

     

    (78)

     

    8

     

    26

     

    8

     

    9

    Earnings (loss) before finance costs

    and income taxes

    597

     

    321

     

    248

     

    20

     

    (416)

     

    74

     

    844

    Depreciation and amortization

    196

     

    151

     

    151

     

    68

     

    20

     

    ‐

     

    586

    EBITDA

    793

     

    472

     

    399

     

    88

     

    (396)

     

    74

     

    1,430

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    10

     

    ‐

     

    10

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Loss related to financial instruments

    in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    15

     

    ‐

     

    15

    ARO/ERL related income for

    non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (35)

     

    ‐

     

    (35)

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    285

     

    ‐

     

    285

    Adjusted EBITDA

    1,128

     

    472

     

    594

     

    88

     

    (121)

     

    74

     

    2,235

     

     

     

    Six Months Ended June 30, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    11,049

     

    1,758

     

    1,996

     

    720

     

    15

     

    ‐

     

    15,538

     

    – intersegment

    ‐

     

    188

     

    491

     

    134

     

    ‐

     

    (813)

     

    ‐

    Sales

    – total

    11,049

     

    1,946

     

    2,487

     

    854

     

    15

     

    (813)

     

    15,538

    Freight, transportation and

    distribution

    ‐

     

    211

     

    273

     

    98

     

    ‐

     

    (116)

     

    466

    Net sales

    11,049

     

    1,735

     

    2,214

     

    756

     

    15

     

    (697)

     

    15,072

    Cost of goods sold

    8,345

     

    820

     

    1,407

     

    724

     

    4

     

    (723)

     

    10,577

    Gross margin

    2,704

     

    915

     

    807

     

    32

     

    11

     

    26

     

    4,495

    Selling expenses (recovery)

    1,703

     

    5

     

    15

     

    3

     

    (5)

     

    (13)

     

    1,708

    General and administrative

    expenses

    88

     

    4

     

    12

     

    3

     

    193

     

    ‐

     

    300

    Provincial mining taxes

    ‐

     

    165

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    165

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    91

     

    ‐

     

    91

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    29

     

    ‐

     

    29

    Other expenses

    79

     

    10

     

    13

     

    13

     

    64

     

    15

     

    194

    Earnings (loss) before finance costs

    and income taxes

    834

     

    731

     

    767

     

    13

     

    (361)

     

    24

     

    2,008

    Depreciation and amortization

    361

     

    345

     

    308

     

    140

     

    31

     

    ‐

     

    1,185

    EBITDA

    1,195

     

    1,076

     

    1,075

     

    153

     

    (330)

     

    24

     

    3,193

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    22

     

    ‐

     

    22

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    91

     

    ‐

     

    91

    ARO/ERL related expenses for

    non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    3

     

    ‐

     

    3

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    29

     

    ‐

     

    29

    Adjusted EBITDA

    1,195

     

    1,076

     

    1,075

     

    153

     

    (185)

     

    24

     

    3,338

     

     

     

    Six Months Ended June 30, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    11,382

     

    1,571

     

    1,794

     

    798

     

    ‐

     

    ‐

     

    15,545

     

    – intersegment

    ‐

     

    192

     

    421

     

    152

     

    ‐

     

    (765)

     

    ‐

    Sales

    – total

    11,382

     

    1,763

     

    2,215

     

    950

     

    ‐

     

    (765)

     

    15,545

    Freight, transportation and

    distribution

    ‐

     

    194

     

    276

     

    119

     

    ‐

     

    (111)

     

    478

    Net sales

    11,382

     

    1,569

     

    1,939

     

    831

     

    ‐

     

    (654)

     

    15,067

    Cost of goods sold

    8,606

     

    717

     

    1,254

     

    733

     

    ‐

     

    (692)

     

    10,618

    Gross margin

    2,776

     

    852

     

    685

     

    98

     

    ‐

     

    38

     

    4,449

    Selling expenses (recovery)

    1,795

     

    6

     

    15

     

    4

     

    (5)

     

    (13)

     

    1,802

    General and administrative

    expenses

    103

     

    5

     

    10

     

    7

     

    187

     

    ‐

     

    312

    Provincial mining taxes

    ‐

     

    136

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    136

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    16

     

    ‐

     

    16

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    328

     

    ‐

     

    328

    Other expenses (income)

    63

     

    1

     

    (111)

     

    16

     

    80

     

    13

     

    62

    Earnings (loss) before finance costs

    and income taxes

    480

     

    704

     

    576

     

    71

     

    (606)

     

    38

     

    1,263

    Depreciation and amortization

    390

     

    298

     

    287

     

    138

     

    38

     

    ‐

     

    1,151

    EBITDA

    870

     

    1,002

     

    863

     

    209

     

    (568)

     

    38

     

    2,414

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    16

     

    ‐

     

    16

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Loss related to financial instruments

    in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    34

     

    ‐

     

    34

    ARO/ERL related income for

    non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (32)

     

    ‐

     

    (32)

    Foreign exchange loss, net of

    related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    328

     

    ‐

     

    328

    Adjusted EBITDA

    1,205

     

    1,002

     

    1,058

     

    209

     

    (222)

     

    38

     

    3,290

     

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Retail sales by product line

     

     

     

     

     

     

     

    Crop nutrients

    3,391

     

    3,281

     

    4,585

     

    4,590

    Crop protection products

    2,666

     

    2,733

     

    3,638

     

    3,847

    Seed

    1,278

     

    1,434

     

    1,810

     

    1,919

    Services and other

    286

     

    292

     

    432

     

    448

    Merchandise

    238

     

    245

     

    427

     

    445

    Nutrien Financial

    135

     

    133

     

    205

     

    199

    Nutrien Financial elimination 1

    (35)

     

    (44)

     

    (48)

     

    (66)

     

    7,959

     

    8,074

     

    11,049

     

    11,382

    Potash sales by geography

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    North America

    382

     

    353

     

    816

     

    873

    Offshore 2

    701

     

    482

     

    1,127

     

    889

    Other potash and purchased products

    2

     

    1

     

    3

     

    1

     

    1,085

     

    836

     

    1,946

     

    1,763

    Nitrogen sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Ammonia

    359

     

    351

     

    599

     

    595

    Urea and ESN®

    530

     

    426

     

    912

     

    792

    Solutions, nitrates and sulfates

    430

     

    343

     

    751

     

    662

    Other nitrogen and purchased products

    94

     

    67

     

    225

     

    166

     

    1,413

     

    1,187

     

    2,487

     

    2,215

    Phosphate sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Fertilizer

    285

     

    291

     

    534

     

    612

    Industrial and feed

    155

     

    155

     

    306

     

    322

    Other phosphate and purchased products

    9

     

    5

     

    14

     

    16

     

    449

     

    451

     

    854

     

    950

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    2 Relates to Canpotex Limited ("Canpotex") (see Note 8) and includes provisional pricing adjustments for the three months ended June 30, 2025 of $27 million (2024 – $(1) million) and the six months ended June 30, 2025 of $58 million (2024 – $11 million).

    Note 3 Other expenses (income)

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Restructuring costs

    21

     

    ‐

     

    22

     

    ‐

    Earnings of equity-accounted investees

    (9)

     

    (30)

     

    (14)

     

    (81)

    Bad debt expense

    38

     

    50

     

    57

     

    63

    Project feasibility costs

    26

     

    28

     

    41

     

    43

    Customer prepayment costs

    19

     

    15

     

    37

     

    31

    Legal expenses

    5

     

    4

     

    7

     

    8

    Insurance recoveries

    ‐

     

    (67)

     

    ‐

     

    (67)

    (Gain) loss on natural gas derivatives not designated as hedge

    ‐

     

    (1)

     

    ‐

     

    2

    Loss related to financial instruments in Argentina

    ‐

     

    15

     

    ‐

     

    34

    ARO/ERL related (income) expenses for non-operating sites ¹

    (2)

     

    (35)

     

    3

     

    (32)

    Other expenses

    28

     

    30

     

    41

     

    61

     

    126

     

    9

     

    194

     

    62

    1 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

    Note 4 Income taxes

    A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Actual effective tax rate on earnings (%)

    23

     

    46

     

    24

     

    42

    Actual effective tax rate including discrete items (%)

    24

     

    43

     

    25

     

    40

    Discrete tax adjustments that impacted the tax rate 1

    22

     

    (23)

     

    27

     

    (20)

    1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

    Note 5 Financial instruments

    Foreign currency derivatives

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Foreign exchange loss

    31

     

    40

     

    17

     

    30

    Hyperinflationary loss

    ‐

     

    20

     

    ‐

     

    65

    (Gain) loss on foreign currency derivatives at fair value through profit or loss

    (9)

     

    225

     

    12

     

    233

    Foreign exchange loss, net of related derivatives

    22

     

    285

     

    29

     

    328

    Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $10,405 million and fair value of $9,929 million as at June 30, 2025. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

    Investments at fair value through other comprehensive income

    During the six months ended June 30, 2025, we fully divested our remaining equity ownership interest in Sinofert Holdings Limited, which had been classified as a financial asset measured at fair value through other comprehensive income. Total proceeds from the sale were $193 million and reflected the fair value of the investment at the date of derecognition. A fair value loss of $18 million related to the investment was recognized in the period in other comprehensive income. Upon derecognition, the cumulative unrealized gain previously recognized in other comprehensive income of $27 million was reclassified to retained earnings.

    Note 6 Debt

    ($ millions, except as otherwise noted)

    Rate of interest (%)

     

    Maturity

     

    Amount

    Senior notes repaid in 2025

    3.000

     

    April 1, 2025

     

    500

     

     

     

     

     

     

    Senior notes issued in 2025

    4.500

     

    March 12, 2027

     

    400

    Senior notes issued in 2025

    5.250

     

    March 12, 2032

     

    600

     

     

     

     

     

    1,000

    The senior notes issued in the six months ended June 30, 2025, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

    Note 7 Share capital

    Share repurchase programs

    The following table summarizes our share repurchase activities during the periods indicated below:

     

    Three Months Ended

     

    Six Months Ended

     

    June 30

     

    June 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Number of common shares repurchased for cancellation

    1,878,972

     

    ‐

     

    4,741,786

     

    ‐

    Average price per share (US dollars)

    56.39

     

    ‐

     

    53.19

     

    ‐

    Total cost, inclusive of tax

    108

     

    ‐

     

    257

     

    ‐

    Subsequent to June 30, 2025, as of August 5, 2025, an additional 990,171 common shares were repurchased for cancellation at a cost of $59 million and an average price per share of $59.93.

    Dividends declared

    We declared a dividend per share of $0.545 (2024 – $0.54) during the three months ended June 30, 2025, payable on July 18, 2025 to shareholders of record on June 30, 2025.

    Note 8 Related party transactions

    We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended June 30, 2025 were $20 million (2024– $40 million) and the six months ended June 30, 2025 were $77 million (2024 – $71 million).

     

     

    As at

     

    As at

    ($ millions)

     

    June 30, 2025

     

    December 31, 2024

    Receivables from Canpotex

     

    425

     

    122

    Payables to Canpotex

     

    89

     

    66

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250729203116/en/

    Jeff Holzman

    Senior Vice President, Investor Relations and FP&A

    (306) 933-8545

    [email protected]

    Get the next $NTR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    7/11/2025$66.00Buy → Hold
    Jefferies
    6/17/2025$68.00Outperform → Mkt Perform
    Raymond James
    5/14/2025$62.00Sector Outperform → Sector Perform
    Scotiabank
    3/13/2025$53.00Sell
    Goldman
    1/21/2025$55.00 → $56.00Overweight → Equal Weight
    Barclays
    1/13/2025$50.00 → $58.00Underweight → Overweight
    Piper Sandler
    1/13/2025$40.00 → $50.00Underweight → Neutral
    Analyst
    12/3/2024$58.00 → $60.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on September 29, 2025. Registered sharehold

    8/6/25 5:30:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Second Quarter 2025 Results

    First half results supported by strong operational performance and favorable fertilizer market fundamentals. Increasing 2025 full-year Potash sales volume guidance range, maintaining capital allocation priorities and continuing to show progress on 2026 performance targets. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its second quarter 2025 results, with net earnings of $1.2 billion ($2.50 diluted net earnings per share). Second quarter 2025 adjusted EBITDA1 was $2.5 billion and adjusted net earnings per share1 was $2.65. "Nutrien delivered growth in earnings and cash flow in the first half of 2025, demonstrating strong

    8/6/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Second Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release second quarter 2025 results after market close on Wednesday, August 6. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EDT on Thursday, August 7. Investors can access the call by dialing 1-800-206-4400 or 1-289-514-5005. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider of crop inputs and services. We o

    7/9/25 5:03:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien downgraded by Jefferies with a new price target

    Jefferies downgraded Nutrien from Buy to Hold and set a new price target of $66.00

    7/11/25 8:11:56 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by Raymond James with a new price target

    Raymond James downgraded Nutrien from Outperform to Mkt Perform and set a new price target of $68.00

    6/17/25 7:48:03 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by Scotiabank with a new price target

    Scotiabank downgraded Nutrien from Sector Outperform to Sector Perform and set a new price target of $62.00

    5/14/25 8:57:32 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Financials

    Live finance-specific insights

    View All

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on September 29, 2025. Registered sharehold

    8/6/25 5:30:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Second Quarter 2025 Results

    First half results supported by strong operational performance and favorable fertilizer market fundamentals. Increasing 2025 full-year Potash sales volume guidance range, maintaining capital allocation priorities and continuing to show progress on 2026 performance targets. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its second quarter 2025 results, with net earnings of $1.2 billion ($2.50 diluted net earnings per share). Second quarter 2025 adjusted EBITDA1 was $2.5 billion and adjusted net earnings per share1 was $2.65. "Nutrien delivered growth in earnings and cash flow in the first half of 2025, demonstrating strong

    8/6/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Second Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release second quarter 2025 results after market close on Wednesday, August 6. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EDT on Thursday, August 7. Investors can access the call by dialing 1-800-206-4400 or 1-289-514-5005. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider of crop inputs and services. We o

    7/9/25 5:03:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    SEC Filings

    View All

    SEC Form SD filed by Nutrien Ltd.

    SD - Nutrien Ltd. (0001725964) (Filer)

    8/7/25 4:18:01 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 11-K filed by Nutrien Ltd.

    11-K - Nutrien Ltd. (0001725964) (Filer)

    6/23/25 5:23:28 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 11-K filed by Nutrien Ltd.

    11-K - Nutrien Ltd. (0001725964) (Filer)

    6/23/25 5:22:27 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2024 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 8, 2024 (the "Meeting"). A total of 369,251,444 common shares, representing 74.66% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.33% 1.67% Maura J. Clark 98.95% 1.05% Russell K. Girling 98.31% 1.69% Michael J. Hennigan 94.88% 5.12% Miranda C. Hubbs 98.48% 1.52%

    5/8/24 7:11:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2023 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 10, 2023 (the "Meeting"). A total of 386,934,221 common shares, representing 77.42% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 95.86% 4.14% Maura J. Clark 95.57% 4.43% Russell K. Girling 93.30% 6.70% Michael J. Hennigan 91.15% 8.85% Miranda C. Hubbs 95.80% 4.20

    5/10/23 7:44:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials